Skip to main content

LEDERLE LEUCOVORIN

Generic: CALCIUM FOLINATE

Verified·Apr 23, 2026
Manufacturer
Pfizer
NDC
73591-5886
RxCUI
197863
Route
ORAL
ICD-10 indication
C18.9

Affordability Check

How much will you actually pay for LEDERLE LEUCOVORIN?

In 30 seconds, see every legitimate way to afford LEDERLE LEUCOVORIN — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About LEDERLE LEUCOVORIN

What is this medication? Lederle Leucovorin is a prescription medication that functions as a derivative of folic acid, specifically known as folinic acid. Its primary role in medical treatment is to act as a rescue agent following high-dose methotrexate chemotherapy. Because methotrexate works by blocking the body's use of folic acid to kill cancer cells, it can also severely damage healthy tissues. This medication provides a source of folate that bypasses the block, thereby protecting the bone marrow and other vital organs from the toxic side effects of the chemotherapy.

Beyond its use in methotrexate rescue therapy, this medication is frequently administered in combination with 5-fluorouracil to enhance the effectiveness of treatment for advanced colorectal cancer. It is also used to treat certain types of anemia, such as megaloblastic anemia resulting from a folic acid deficiency when oral supplementation is not feasible. Additionally, it may be prescribed to counteract the toxic effects of accidental overdoses of medications that act as folic acid antagonists.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How LEDERLE LEUCOVORIN appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-04-30).

Covered by plans

71%

3,932 of 5,509 plans

Most common tier

Tier 2

On 40% of covering formularies

Prior authorization required

0%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)67
20%
Tier 2 (generic)133
40%
Tier 3 (preferred brand)109
33%
Tier 4 (non-preferred brand)20
6%

Step therapy: 0% of formularies

Quantity limits: 0% of formularies

Coverage breadth: 329 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.